Table 1 Baseline characteristics of all donors

From: SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

Cohort

Gender distribution (%)

Average age (range)

Disease severity

ICU (yes/no)

Average sampling day (range)

Patients with COVID-19

Male, 72%; female, 28%

52.6 years (21–81 years)

Mild, 38.9%; severe, 27.8%; critical, 33.3%

No, 44.4%; yes, 55.6%

14.9 days (2–39 days)

Healthy donors

Male, 31%; female, 59%

41.9 (20–64 years)

NA

NA

NA

  1. ‘Sampling day’ indicates the day of sampling in days after the onset of symptoms. ICU, intensive care unit. NA, not applicable.